2-METHOXY-4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENOL
Product Information
Molecular Formula
C13H19BO4
Molecular Weight
250.1
Description
2-METHOXY-4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENOL is a biomedical compound bestowed with profound medicinal prospects. Renowned for its extraordinary antioxidant attributes, this wonderous solution finds extensive applications in remedial measures targeted at oxidative stress-induced illnesses. Given its distinctive and intricate molecular configuration, this exquisite entity emerges as an auspicious contender for pioneering the creation of groundbreaking pharmaceuticals, effectively countering a wide array of disorders arising from oxidative impairment.
Synonyms
4-HYDROXY-3-METHOXYPHENYLBORONIC ACID, PINACOL CYCLIC ESTER; 4-HYDROXY-3-METHOXYPHENYLBORONIC ACID PINACOL ESTER; 2-METHOXY-4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENOL; 2-Methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol,min.97%; 2-METH
IUPAC Name
2-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol
SMILES
B1(OC(C(O1)(C)C)(C)C)C2=CC(=C(C=C2)O)OC
InChI
InChI=1S/C13H19BO4/c1-12(2)13(3,4)18-14(17-12)9-6-7-10(15)11(8-9)16-5/h6-8,15H,1-5H3
InChI Key
WFSJROCEOJANPD-UHFFFAOYSA-N
Boiling Point
367.3°C at 760mmHg
Melting Point
105-109°C(lit.)
Flash Point
Not applicable
Purity
96
Density
1.11g/cm3
Appearance
white to cream crystalline powder
Storage
Refrigerator (+4°C)
Safety Information
Hazards
H315 - H319 - H335
Precautionary Statement
P302 + P352 - P305 + P351 + P338
Computed Properties
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
4
Rotatable Bond Count
2
Exact Mass
250.1376392 g/mol
Monoisotopic Mass
250.1376392 g/mol
Topological Polar Surface Area
47.9Ų
Heavy Atom Count
18
Formal Charge
0
Complexity
289
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
1
Compound Is Canonicalized
Yes
Patents
| Publication Number | Title | Priority Date |
|---|---|---|
| KR-102259694-B1 | Synthesis of new compounds via oxidative dearomatization of phenols and application thereof | 2019-11-11 |
| KR-20210057258-A | Synthesis of new compounds via oxidative dearomatization of phenols and application thereof | 2019-11-11 |
| WO-2021055295-A1 | Brd9 bifunctional degraders and their methods of use | 2019-09-16 |
| TW-202123942-A | Brd9 bifunctional degraders and their methods of use | 2019-09-16 |
| CN-112341434-A | PI3K/mTOR protein degradation targeting chimera compound and preparation method and medical application thereof | 2019-08-08 |
| CN-112341434-B | PI3K/mTOR protein degradation targeting chimera compound and preparation method and medical application thereof | 2019-08-08 |
| US-2020397697-A1 | Formulations of tie-2 activators and methods of use thereof | 2019-06-24 |
| TW-202019946-A | Acetamide compound with induction effect of BIT protein decomposition and its use as medicine | 2018-07-04 |
| CN-110997671-A | Azaindole compounds as histone methyltransferase inhibitors | 2017-06-09 |
| TW-201920165-A | Nitrogen-based compound as a histone methyltransferase inhibitor | 2017-06-09 |
